This paper is only available as a PDF. To read, Please Download here.
Abstract
This paper provides a consumer's perspective on an important issue that has a profound
impact on all of us: the US Food and Drug Administration (FDA) Modernization Act of
1997. In addition, it provides some background information on the National Consumers
League, an organization that promotes consumer safety and protection with the FDA
and its predecessors.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinical TherapeuticsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Implementing the FDA Modernization Act.JAMA. 1998; 279: 815-816
- Drug prescribing information.in: 52nd ed. Physicians' Desk Reference. Medical Economics Co, Montvale, NJ1998: 2485
- Patient testing and labeling strengthened for Rezulin.FDA Talk Paper. 1 December 1997;
- Concern expressed about FDA reform legislation.JAMA. 1997; 278: 459
- Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies.JAMA. 1998; 279: 1200-1205
Article info
Identification
Copyright
© 1998 Published by Elsevier Inc.
